MedTrace Logo

Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

NCT06272136 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-10-01

No results posted yet for this study

Summary

This is a single-centre, multiple cohort, open study.

Conditions

Interventions

DEVICE

Clinical Demo 2.0

During the different glycaemia states, transcutaneous spectral data are collected continuously with the device and paired with reference measurements (venous blood and interstitial fluid)

Sponsors & Collaborators

  • Profil Institut für Stoffwechselforschung GmbH

    collaborator INDUSTRY

  • Liom Health AG

    lead INDUSTRY

Principal Investigators

  • Marc Stoffel, MD · Profil for Stoffwechselforschung GmbH, Neuss, Germany

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-23
Primary Completion
2025-07-21
Completion
2025-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06272136 on ClinicalTrials.gov